Functional polymorphisms in transforming growth factor-beta-1 (TGFβ-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection

Background. The risk of renal scar formation following urinary tract infection (UTI) varies markedly between individuals. We sought to investigate a possible role of the common polymorphisms in the gene encoding for VEGF and TGFβ-1, key regulators of tissue repair, in renal scarring. Methods. Acute...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nephrology, dialysis, transplantation dialysis, transplantation, 2010-03, Vol.25 (3), p.779-785
Hauptverfasser: Hussein, Almontaser, Askar, Eman, Elsaeid, Moustafa, Schaefer, Franz
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 785
container_issue 3
container_start_page 779
container_title Nephrology, dialysis, transplantation
container_volume 25
creator Hussein, Almontaser
Askar, Eman
Elsaeid, Moustafa
Schaefer, Franz
description Background. The risk of renal scar formation following urinary tract infection (UTI) varies markedly between individuals. We sought to investigate a possible role of the common polymorphisms in the gene encoding for VEGF and TGFβ-1, key regulators of tissue repair, in renal scarring. Methods. Acute pyelonephritis was diagnosed in 104 children (63 males) aged 2 months to 12 years by urine culture and 99Tc-DMSA renal scan. A follow-up isotope scan was performed 4–6 months later to identify new renal scar formation. Vesicoureteral reflux (VUR) was examined by micturating cystourethrogram. Controls comprised 300 healthy children with no evidence of renal disease. Three single-nucleotide polymorphisms (SNPs) in the TGFβ-1 (−800 A/G, −509 C/T and 869 C/T) and four SNPs in the VEGF gene (−2578 C/A, −1154 G/A, −460 T/C and +405 G/C) were genotyped in all subjects. Results. Forty-six of the 104 patients developed renal parenchymal scarring (44.2%). VUR was found in 35.6%. The −509 T allele in the TGFβ-1 promoter was significantly more common in cases with renal scarring (51%) than in non-scarring patients (22.4%) and controls (23.6%) (both P < 0.0001). At the haplotype level, the GTC combination at −800/−509/+869 was strongly associated with renal scarring (P = 0.0002). VEGF−460 CC was more common in UTI cases with renal scarring than in non-scarring patients and controls (P = 0.03 and 0.001, respectively). Multiple logistic regression testing identified the presence of VUR (odds ratio 12.4, CI 3.8–40; P < 0.001) and the TGFβ-1 −509 T allele (OR 6.1, CI 2.4–15.5; P < 0.001) as independent risk factors for renal scarring after UTI. In contrast, age, gender and the type of underlying organism were not predictive of renal scarring. Conclusions. Activating variants in the TGFβ-1 and VEGF gene promoters are associated with post-UTI renal scar formation in children. The TGFβ-1 509T allele predicts renal scarring independent of VUR.
doi_str_mv 10.1093/ndt/gfp532
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733133409</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/ndt/gfp532</oup_id><sourcerecordid>733133409</sourcerecordid><originalsourceid>FETCH-LOGICAL-c384t-768465521ec33ee42ddef24346ea7cad954c42ffd8fb55e82563f7642aab2d2f3</originalsourceid><addsrcrecordid>eNp9kctuEzEUhi0EoiGw4QGQN4gWaej4NpclqpoUUcSmXNSN5fiSMfWMp7aHktfiQZB4I5wmCmLD6hzpfP7Pf_wD8ByVb1DZktNBpdO1GRnBD8AM0aosMGnYQzDLQ1SUrGyPwJMYv5Vl2eK6fgyOUNtUiCA6A78X0yCT9YNwcPRu0_swdjb2EdoBpiCGaHzo7bCG6-DvUgeNkMmHYqWTKBA8vloufv0s0AkUg4LfRZSTEwHqQfnUaWez6j_v4PHn8-XiBK71oCPsvbJmA4ONN9AbGPS9C5Gr7DZ97qMUIWyXG--cv9t2srNOdd4rOOWJCJutS5myXaPvD3kKHhnhon62r3PwaXF-dXZRXH5cvjt7e1lI0tBU1FVDK8Yw0pIQrSlWShtMCa20qKVQLaOSYmNUY1aM6Qazipi6oliIFVbYkDl4tdMdg7-ddEy8t1Fq58Sg_RR5TQgihOYM5uD1jpTBxxi04WOwfbbOUcm3CfKcIN8lmOEXe9lp1Wv1F91HloGXeyD_tnAmZyRtPHAYV03JstkD56fx_wuLHWdj0j8OpAg3vKpJzfjF12v-4UuFmwa_59fkDw-Oxlo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733133409</pqid></control><display><type>article</type><title>Functional polymorphisms in transforming growth factor-beta-1 (TGFβ-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>Alma/SFX Local Collection</source><creator>Hussein, Almontaser ; Askar, Eman ; Elsaeid, Moustafa ; Schaefer, Franz</creator><creatorcontrib>Hussein, Almontaser ; Askar, Eman ; Elsaeid, Moustafa ; Schaefer, Franz</creatorcontrib><description>Background. The risk of renal scar formation following urinary tract infection (UTI) varies markedly between individuals. We sought to investigate a possible role of the common polymorphisms in the gene encoding for VEGF and TGFβ-1, key regulators of tissue repair, in renal scarring. Methods. Acute pyelonephritis was diagnosed in 104 children (63 males) aged 2 months to 12 years by urine culture and 99Tc-DMSA renal scan. A follow-up isotope scan was performed 4–6 months later to identify new renal scar formation. Vesicoureteral reflux (VUR) was examined by micturating cystourethrogram. Controls comprised 300 healthy children with no evidence of renal disease. Three single-nucleotide polymorphisms (SNPs) in the TGFβ-1 (−800 A/G, −509 C/T and 869 C/T) and four SNPs in the VEGF gene (−2578 C/A, −1154 G/A, −460 T/C and +405 G/C) were genotyped in all subjects. Results. Forty-six of the 104 patients developed renal parenchymal scarring (44.2%). VUR was found in 35.6%. The −509 T allele in the TGFβ-1 promoter was significantly more common in cases with renal scarring (51%) than in non-scarring patients (22.4%) and controls (23.6%) (both P &lt; 0.0001). At the haplotype level, the GTC combination at −800/−509/+869 was strongly associated with renal scarring (P = 0.0002). VEGF−460 CC was more common in UTI cases with renal scarring than in non-scarring patients and controls (P = 0.03 and 0.001, respectively). Multiple logistic regression testing identified the presence of VUR (odds ratio 12.4, CI 3.8–40; P &lt; 0.001) and the TGFβ-1 −509 T allele (OR 6.1, CI 2.4–15.5; P &lt; 0.001) as independent risk factors for renal scarring after UTI. In contrast, age, gender and the type of underlying organism were not predictive of renal scarring. Conclusions. Activating variants in the TGFβ-1 and VEGF gene promoters are associated with post-UTI renal scar formation in children. The TGFβ-1 509T allele predicts renal scarring independent of VUR.</description><identifier>ISSN: 0931-0509</identifier><identifier>EISSN: 1460-2385</identifier><identifier>DOI: 10.1093/ndt/gfp532</identifier><identifier>PMID: 19861314</identifier><identifier>CODEN: NDTREA</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Alleles ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Case-Control Studies ; Child ; Child, Preschool ; Cicatrix - genetics ; Emergency and intensive care: renal failure. Dialysis management ; Female ; Genetic Predisposition to Disease - genetics ; Genotype ; haplotypes ; Haplotypes - genetics ; Humans ; Infant ; Intensive care medicine ; Kidney ; Logistic Models ; Male ; Medical sciences ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Polymorphism, Single Nucleotide - genetics ; polymorphisms ; renal ; Renal failure ; scarring ; TGFB1 ; Transforming Growth Factor beta1 - genetics ; Urinary Tract Infections - complications ; Vascular Endothelial Growth Factor A - genetics</subject><ispartof>Nephrology, dialysis, transplantation, 2010-03, Vol.25 (3), p.779-785</ispartof><rights>Oxford University Press © The Author 2009. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org 2009</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c384t-768465521ec33ee42ddef24346ea7cad954c42ffd8fb55e82563f7642aab2d2f3</citedby><cites>FETCH-LOGICAL-c384t-768465521ec33ee42ddef24346ea7cad954c42ffd8fb55e82563f7642aab2d2f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1584,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22680556$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19861314$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hussein, Almontaser</creatorcontrib><creatorcontrib>Askar, Eman</creatorcontrib><creatorcontrib>Elsaeid, Moustafa</creatorcontrib><creatorcontrib>Schaefer, Franz</creatorcontrib><title>Functional polymorphisms in transforming growth factor-beta-1 (TGFβ-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection</title><title>Nephrology, dialysis, transplantation</title><addtitle>Nephrol Dial Transplant</addtitle><addtitle>Nephrol Dial Transplant</addtitle><description>Background. The risk of renal scar formation following urinary tract infection (UTI) varies markedly between individuals. We sought to investigate a possible role of the common polymorphisms in the gene encoding for VEGF and TGFβ-1, key regulators of tissue repair, in renal scarring. Methods. Acute pyelonephritis was diagnosed in 104 children (63 males) aged 2 months to 12 years by urine culture and 99Tc-DMSA renal scan. A follow-up isotope scan was performed 4–6 months later to identify new renal scar formation. Vesicoureteral reflux (VUR) was examined by micturating cystourethrogram. Controls comprised 300 healthy children with no evidence of renal disease. Three single-nucleotide polymorphisms (SNPs) in the TGFβ-1 (−800 A/G, −509 C/T and 869 C/T) and four SNPs in the VEGF gene (−2578 C/A, −1154 G/A, −460 T/C and +405 G/C) were genotyped in all subjects. Results. Forty-six of the 104 patients developed renal parenchymal scarring (44.2%). VUR was found in 35.6%. The −509 T allele in the TGFβ-1 promoter was significantly more common in cases with renal scarring (51%) than in non-scarring patients (22.4%) and controls (23.6%) (both P &lt; 0.0001). At the haplotype level, the GTC combination at −800/−509/+869 was strongly associated with renal scarring (P = 0.0002). VEGF−460 CC was more common in UTI cases with renal scarring than in non-scarring patients and controls (P = 0.03 and 0.001, respectively). Multiple logistic regression testing identified the presence of VUR (odds ratio 12.4, CI 3.8–40; P &lt; 0.001) and the TGFβ-1 −509 T allele (OR 6.1, CI 2.4–15.5; P &lt; 0.001) as independent risk factors for renal scarring after UTI. In contrast, age, gender and the type of underlying organism were not predictive of renal scarring. Conclusions. Activating variants in the TGFβ-1 and VEGF gene promoters are associated with post-UTI renal scar formation in children. The TGFβ-1 509T allele predicts renal scarring independent of VUR.</description><subject>Alleles</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Cicatrix - genetics</subject><subject>Emergency and intensive care: renal failure. Dialysis management</subject><subject>Female</subject><subject>Genetic Predisposition to Disease - genetics</subject><subject>Genotype</subject><subject>haplotypes</subject><subject>Haplotypes - genetics</subject><subject>Humans</subject><subject>Infant</subject><subject>Intensive care medicine</subject><subject>Kidney</subject><subject>Logistic Models</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>polymorphisms</subject><subject>renal</subject><subject>Renal failure</subject><subject>scarring</subject><subject>TGFB1</subject><subject>Transforming Growth Factor beta1 - genetics</subject><subject>Urinary Tract Infections - complications</subject><subject>Vascular Endothelial Growth Factor A - genetics</subject><issn>0931-0509</issn><issn>1460-2385</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kctuEzEUhi0EoiGw4QGQN4gWaej4NpclqpoUUcSmXNSN5fiSMfWMp7aHktfiQZB4I5wmCmLD6hzpfP7Pf_wD8ByVb1DZktNBpdO1GRnBD8AM0aosMGnYQzDLQ1SUrGyPwJMYv5Vl2eK6fgyOUNtUiCA6A78X0yCT9YNwcPRu0_swdjb2EdoBpiCGaHzo7bCG6-DvUgeNkMmHYqWTKBA8vloufv0s0AkUg4LfRZSTEwHqQfnUaWez6j_v4PHn8-XiBK71oCPsvbJmA4ONN9AbGPS9C5Gr7DZ97qMUIWyXG--cv9t2srNOdd4rOOWJCJutS5myXaPvD3kKHhnhon62r3PwaXF-dXZRXH5cvjt7e1lI0tBU1FVDK8Yw0pIQrSlWShtMCa20qKVQLaOSYmNUY1aM6Qazipi6oliIFVbYkDl4tdMdg7-ddEy8t1Fq58Sg_RR5TQgihOYM5uD1jpTBxxi04WOwfbbOUcm3CfKcIN8lmOEXe9lp1Wv1F91HloGXeyD_tnAmZyRtPHAYV03JstkD56fx_wuLHWdj0j8OpAg3vKpJzfjF12v-4UuFmwa_59fkDw-Oxlo</recordid><startdate>20100301</startdate><enddate>20100301</enddate><creator>Hussein, Almontaser</creator><creator>Askar, Eman</creator><creator>Elsaeid, Moustafa</creator><creator>Schaefer, Franz</creator><general>Oxford University Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20100301</creationdate><title>Functional polymorphisms in transforming growth factor-beta-1 (TGFβ-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection</title><author>Hussein, Almontaser ; Askar, Eman ; Elsaeid, Moustafa ; Schaefer, Franz</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c384t-768465521ec33ee42ddef24346ea7cad954c42ffd8fb55e82563f7642aab2d2f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Alleles</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Cicatrix - genetics</topic><topic>Emergency and intensive care: renal failure. Dialysis management</topic><topic>Female</topic><topic>Genetic Predisposition to Disease - genetics</topic><topic>Genotype</topic><topic>haplotypes</topic><topic>Haplotypes - genetics</topic><topic>Humans</topic><topic>Infant</topic><topic>Intensive care medicine</topic><topic>Kidney</topic><topic>Logistic Models</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>polymorphisms</topic><topic>renal</topic><topic>Renal failure</topic><topic>scarring</topic><topic>TGFB1</topic><topic>Transforming Growth Factor beta1 - genetics</topic><topic>Urinary Tract Infections - complications</topic><topic>Vascular Endothelial Growth Factor A - genetics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hussein, Almontaser</creatorcontrib><creatorcontrib>Askar, Eman</creatorcontrib><creatorcontrib>Elsaeid, Moustafa</creatorcontrib><creatorcontrib>Schaefer, Franz</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nephrology, dialysis, transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hussein, Almontaser</au><au>Askar, Eman</au><au>Elsaeid, Moustafa</au><au>Schaefer, Franz</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Functional polymorphisms in transforming growth factor-beta-1 (TGFβ-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection</atitle><jtitle>Nephrology, dialysis, transplantation</jtitle><stitle>Nephrol Dial Transplant</stitle><addtitle>Nephrol Dial Transplant</addtitle><date>2010-03-01</date><risdate>2010</risdate><volume>25</volume><issue>3</issue><spage>779</spage><epage>785</epage><pages>779-785</pages><issn>0931-0509</issn><eissn>1460-2385</eissn><coden>NDTREA</coden><abstract>Background. The risk of renal scar formation following urinary tract infection (UTI) varies markedly between individuals. We sought to investigate a possible role of the common polymorphisms in the gene encoding for VEGF and TGFβ-1, key regulators of tissue repair, in renal scarring. Methods. Acute pyelonephritis was diagnosed in 104 children (63 males) aged 2 months to 12 years by urine culture and 99Tc-DMSA renal scan. A follow-up isotope scan was performed 4–6 months later to identify new renal scar formation. Vesicoureteral reflux (VUR) was examined by micturating cystourethrogram. Controls comprised 300 healthy children with no evidence of renal disease. Three single-nucleotide polymorphisms (SNPs) in the TGFβ-1 (−800 A/G, −509 C/T and 869 C/T) and four SNPs in the VEGF gene (−2578 C/A, −1154 G/A, −460 T/C and +405 G/C) were genotyped in all subjects. Results. Forty-six of the 104 patients developed renal parenchymal scarring (44.2%). VUR was found in 35.6%. The −509 T allele in the TGFβ-1 promoter was significantly more common in cases with renal scarring (51%) than in non-scarring patients (22.4%) and controls (23.6%) (both P &lt; 0.0001). At the haplotype level, the GTC combination at −800/−509/+869 was strongly associated with renal scarring (P = 0.0002). VEGF−460 CC was more common in UTI cases with renal scarring than in non-scarring patients and controls (P = 0.03 and 0.001, respectively). Multiple logistic regression testing identified the presence of VUR (odds ratio 12.4, CI 3.8–40; P &lt; 0.001) and the TGFβ-1 −509 T allele (OR 6.1, CI 2.4–15.5; P &lt; 0.001) as independent risk factors for renal scarring after UTI. In contrast, age, gender and the type of underlying organism were not predictive of renal scarring. Conclusions. Activating variants in the TGFβ-1 and VEGF gene promoters are associated with post-UTI renal scar formation in children. The TGFβ-1 509T allele predicts renal scarring independent of VUR.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>19861314</pmid><doi>10.1093/ndt/gfp532</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0931-0509
ispartof Nephrology, dialysis, transplantation, 2010-03, Vol.25 (3), p.779-785
issn 0931-0509
1460-2385
language eng
recordid cdi_proquest_miscellaneous_733133409
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Oxford University Press Journals All Titles (1996-Current); Alma/SFX Local Collection
subjects Alleles
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Case-Control Studies
Child
Child, Preschool
Cicatrix - genetics
Emergency and intensive care: renal failure. Dialysis management
Female
Genetic Predisposition to Disease - genetics
Genotype
haplotypes
Haplotypes - genetics
Humans
Infant
Intensive care medicine
Kidney
Logistic Models
Male
Medical sciences
Nephrology. Urinary tract diseases
Nephropathies. Renovascular diseases. Renal failure
Polymorphism, Single Nucleotide - genetics
polymorphisms
renal
Renal failure
scarring
TGFB1
Transforming Growth Factor beta1 - genetics
Urinary Tract Infections - complications
Vascular Endothelial Growth Factor A - genetics
title Functional polymorphisms in transforming growth factor-beta-1 (TGFβ-1) and vascular endothelial growth factor (VEGF) genes modify risk of renal parenchymal scarring following childhood urinary tract infection
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T17%3A23%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Functional%20polymorphisms%20in%20transforming%20growth%20factor-beta-1%20(TGF%CE%B2-1)%20and%20vascular%20endothelial%20growth%20factor%20(VEGF)%20genes%20modify%20risk%20of%20renal%20parenchymal%20scarring%20following%20childhood%20urinary%20tract%20infection&rft.jtitle=Nephrology,%20dialysis,%20transplantation&rft.au=Hussein,%20Almontaser&rft.date=2010-03-01&rft.volume=25&rft.issue=3&rft.spage=779&rft.epage=785&rft.pages=779-785&rft.issn=0931-0509&rft.eissn=1460-2385&rft.coden=NDTREA&rft_id=info:doi/10.1093/ndt/gfp532&rft_dat=%3Cproquest_cross%3E733133409%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733133409&rft_id=info:pmid/19861314&rft_oup_id=10.1093/ndt/gfp532&rfr_iscdi=true